Longxuan Wang provides trusted economic analysis in litigation and advisory matters pertaining to securities and finances and mass torts. He has experience managing and consulting on over 50 cases involving securities class actions, mass tort and product liability forecasts, breaches of contract, investment valuations, and regulatory investigations. Mr. Wang works with clients in various markets and jurisdictions including the US, Canada, Mexico, and China.
Mr. Wang has extensive experience applying economic, statistical, and financial models to the quantification of damages and potential exposures. He has performed damages analyses for matters involving alleged violations of securities and ERISA laws, alleged collusive trading strategies in sovereign bonds markets, and alleged breaches of contract. He has assessed potential exposure from product liability and mass tort issues for pharmaceutical companies, consumer product companies, industrial machinery manufacturers, and pest control service providers. In addition, Mr. Wang has worked on matters involving valuations of early-stage companies and evaluations of new business opportunities. He recently testified at a trial in Macao, China, on issues related to an alleged breach of contract.